首页> 外文期刊>Die Pharmazie >Comparative pharmacokinetics of aloe-emodin, rhein and emodin determined by liquid chromatography-mass spectrometry after oral administration of a rhubarb peony decoction and rhubarb extract to rats
【24h】

Comparative pharmacokinetics of aloe-emodin, rhein and emodin determined by liquid chromatography-mass spectrometry after oral administration of a rhubarb peony decoction and rhubarb extract to rats

机译:大鼠大黄rh药汤和大黄提取物口服后用液相色谱-质谱法测定芦荟大黄素,大黄酸和大黄素的比较药代动力学

获取原文
获取原文并翻译 | 示例
       

摘要

This study aimed to clarify the rationality of herbaceous compatibility of a rhubarb peony decoction (Da-Huang-Mu-Dan-Tang, RPD) by comparing the pharmacokinetics of aloe-emodin, rhein and emodin in rats' plasma after oral administration of RPD and rhubarb extract. A rapid, sensitive LC-MS method was developed and validated for the determination of the plasma concentrations of the three analytes after oral administration RPD and rhubarb extract. The developed method was successfully applied to a pharma-cokinetic study of aloe-emodin, rhein and emodin in rats' plasma after oral administration. Compared with administration of single rhubarb, the C_(max) of rhein in RPD was decreased significantly (p<0.05). Meanwhile, the T_(1/2) of aloe-emodin and emodin were increased significantly (p<0.05) after administration of RPD. In addition, the T_(max) of rhein and emodin were also increased significantly (p<0.05) in RPD. These results indicated that the absorption of rhein in rats was suppressed after oral administration RPD. Moreover, The time for rhein and emodin to reach the peak concentration was delayed and the elimination of aloe-emodin and emodin was also postponed in RPD. This study could provide a meaningful basis for evaluating the clinical application of traditional Chinese medicine in terms of pharmacokinetics.
机译:本研究旨在通过比较芦荟大黄素,大黄酸和大黄素口服后RPD和大黄素在大鼠血浆中的药代动力学,阐明大黄牡丹汤(大黄木丹汤,RPD)与草皮的相容性的合理性。大黄提取物。建立了一种快速,灵敏的LC-MS方法,并经过验证可用于口服RPD和大黄提取物后测定三种分析物的血浆浓度。该方法成功应用于口服后大鼠血浆中芦荟大黄素,大黄酸和大黄素的药代动力学研究。与单一大黄相比,RPD中大黄酸的C_(max)显着降低(p <0.05)。同时,RPD给药后芦荟大黄素和大黄素的T_(1/2)显着增加(p <0.05)。此外,RPD中大黄酸和大黄素的T_(max)也显着增加(p <0.05)。这些结果表明口服RPD后大黄酸在大鼠中的吸收被抑制。此外,在RPD中,大黄酸和大黄素达到峰值浓度的时间被延迟,芦荟大黄素和大黄素的消除也被推迟。该研究可以为评价中药在药代动力学方面的临床应用提供有意义的依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号